These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13211649)

  • 41. The use of casual urine specimens in the evalation of the excretion rates of thiamine, riboflavin and N1-methylnicotinamide.
    PLOUGH IC; CONSOLAZIO CF
    J Nutr; 1959 Dec; 69():365-70. PubMed ID: 14433528
    [No Abstract]   [Full Text] [Related]  

  • 42. [Determination of urinary N. methyl nicotinamide and biochemical diagnosis of factor PP deficiency].
    PAYVA CA
    Rev Sanid Mil Peru; 1952 Mar; 25(66):409-17. PubMed ID: 14949717
    [No Abstract]   [Full Text] [Related]  

  • 43. Simultaneous determination of niacin and its metabolites--nicotinamide, nicotinuric acid and N-methyl-2-pyridone-5-carboxamide--in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.
    Inamadugu JK; Damaramadugu R; Mullangi R; Ponneri V
    Biomed Chromatogr; 2010 Oct; 24(10):1059-74. PubMed ID: 20853461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct determination of niacinamide in multivitamin preparations.
    PELLETIER O; CAMPBELL JA
    J Pharm Sci; 1961 Nov; 50():926-8. PubMed ID: 14484985
    [No Abstract]   [Full Text] [Related]  

  • 45. Microdetermination of N1-methyl-2-pyridone-5-carboxamide, a major metabolite of nicotinic acid and nicotinamide, in urine by high-performance liquid chromatography.
    Shibata K; Kawada T; Iwai K
    J Chromatogr; 1987 Jun; 417(1):173-7. PubMed ID: 2957383
    [No Abstract]   [Full Text] [Related]  

  • 46. Arteriosclerotic syndromes; niacinamide hydroiodide (parenteral) treatment.
    FEINBLATT TM; FEINBLATT HM; FERGUSON EA
    Med Times; 1956 Jul; 84(7):741-3. PubMed ID: 13347482
    [No Abstract]   [Full Text] [Related]  

  • 47. Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.
    Menon RM; Adams MH; González MA; Tolbert DS; Leu JH; Cefali EA
    Int J Clin Pharmacol Ther; 2007 Aug; 45(8):448-54. PubMed ID: 17725178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin B6 depletion in man: urinary excretion of quinolinic acid and niacin metabolites.
    Brown RR; Yess N; Price JM; Linkswiler H; Swan P; Hankes LV
    J Nutr; 1965 Dec; 87(4):419-23. PubMed ID: 4221054
    [No Abstract]   [Full Text] [Related]  

  • 49. Nicotinamide haemochrome as a derivative for the colorimetric determination of the total haem pigments in blood.
    WHITE FD; DELORY GE; CHRISTIE KA; DUDLEY EA
    Can J Med Sci; 1952 Apr; 30(2):136-42. PubMed ID: 14916348
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapy of migraine with nicotinic acid amide (Benicot)].
    FRITTON M
    Medizinische; 1955 Sep; (38):1350-1. PubMed ID: 13272545
    [No Abstract]   [Full Text] [Related]  

  • 51. A modification in the synthesis of N-methylnicotinamide chloride (3-carbamyl-1-methyl-pyridinium chloride).
    TILLOTSON JA; ZIPORIN ZZ
    Anal Biochem; 1960 Nov; 1():273-4. PubMed ID: 13776918
    [No Abstract]   [Full Text] [Related]  

  • 52. [VARIATIONS OF URINARY ELIMINATION OF NICOTINIC METABOLITES DURING THE MENSTRUAL CYCLE].
    MAINARDI L; SACCHETTI G; TENCONI LT
    Acta Vitaminol; 1965; 19():15-20. PubMed ID: 14325808
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of excess intake of leucine and valine deficiency on tryptophan and niacin metabolites in humans.
    Nakagawa I; Oguri S; Sasaki A; Kajimoto M; Sasaki M
    J Nutr; 1975 Oct; 105(10):1241-52. PubMed ID: 125788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nicotinamide content of some normal and malignant tissues; the apparent absence of niacin in epidermis.
    CARRUTHERS C; SUNTZEFF V
    Cancer Res; 1952 Dec; 12(12):879-85. PubMed ID: 13009675
    [No Abstract]   [Full Text] [Related]  

  • 55. Fluorometric determination of nicotinamide and N'-methylnicotinamide and theri urinary excretion in man.
    KOTAKE Y; TSUJI M; HASEGAWA N
    J Vitaminol (Kyoto); 1960 Dec; 6():271-7. PubMed ID: 13753467
    [No Abstract]   [Full Text] [Related]  

  • 56. Metabolic response of humans to ingestion of nicotinic acid and nicotinamide.
    Mrochek JE; Jolley RL; Young DS; Turner WJ
    Clin Chem; 1976 Nov; 22(11):1821-7. PubMed ID: 135660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of nicotinic acid, nicotinamide, and placebo on the chronic schizophrenic.
    ASHBY WR; COLLINS GH; BASSETT M
    J Ment Sci; 1960 Oct; 106():1555-9. PubMed ID: 13684724
    [No Abstract]   [Full Text] [Related]  

  • 58. [Side effects to the clinical use of chloramphenicol, chlortetracycline and oxytetracycline; variations fecal urobilinogen, prothrombin plasma and urinary excretion of riboflavin and N-1-methyl-nicotinamide].
    CONCHA E; VEIT O
    Med Panam; 1956 Oct; 7(4):271-6. PubMed ID: 13386689
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on nicotinamide inhibitors.
    COTE L; OLESON JJ; WILLIAMS JH
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):434-6. PubMed ID: 14949076
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of arteriosclerosis and vague abdominal distress with niacinamide hydroiodide, without side-effects.
    FEINBLATT TM; FEINBLATT HM; FERGUSON EA
    Am J Dig Dis; 1955 Jan; 22(1):5-6. PubMed ID: 13228382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.